Robin J. McGarry
Corporate Officer/Principal chez Astellas Pharma Global Development, Inc.
Provenance du réseau au premier degré de Robin J. McGarry
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Robin J. McGarry via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTELLAS PHARMA INC. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
| Central Pennsylvania Clinic | Director/Board Member | ||
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member | |
| University of Medicine & Dentistry of New Jersey | College/University | Doctorate Degree | |
| LUMINEX CORPORATION | Medical Specialties | Director/Board Member | |
| Kalamazoo College | College/University | Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
| Keck Graduate Institute of Applied Life Sciences | College/University | Director/Board Member | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Pharmaceuticals: Major | Chief Executive Officer | |
CirculoGene Theranostics, Inc.
 CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Medical Specialties | Director/Board Member | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
Personalized Medicine Coalition
 Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry. | Miscellaneous Commercial Services | Director/Board Member | |
| ENTRADA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| AMYLYX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Case Western Reserve University School of Medicine | College/University | Doctorate Degree | |
| University of Toledo (Ohio) | College/University | Undergraduate Degree | |
Halloran Consulting Group, Inc.
 Halloran Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Halloran Consulting Group, Inc. provides management consulting services for the life science industry. Its services include clinical development, due diligence, organizational development, program management, gap analysis, clinical finance, change management, vendor management, inspection readiness, training and technology adoption. The company was founded by Laurie Halloran in 1998 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| University of the Witwatersrand | College/University | Undergraduate Degree | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Mississippi Medical Center | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 32 |
| Japon | 2 |
| Afrique du Sud | 2 |
| Irlande | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 20 |
| Consumer Services | 13 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 12 |
| Chief Tech/Sci/R&D Officer | 9 |
| Corporate Officer/Principal | 9 |
| Doctorate Degree | 5 |
| President | 4 |
Relations les plus connectées
| Insiders | |
|---|---|
| Stephen Eck | 15 |
| Sef P. Kurstjens | 10 |
| Bernhardt Zeiher | 8 |
| Mark A. Weinberg | 7 |
| Jeannette A. Barrett | 2 |
- Bourse
- Insiders
- Robin J. McGarry
- Connexions Sociétés
